An observational study in Back Pain, Low, sponsored by University of Southern Denmark. Recruiting at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-12-05.
Sponsored by University of Southern Denmark · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 56 studies in Low Back Pain with a site in Denmark — 5 open to participants now, 6 under way, none of them phase 3. Low Back Pain · Denmark.
Among the 56 studies in Low Back Pain with a site in Denmark, this one has the largest planned enrollment of the 17 observational ones that give a count, is one of 6 that started in 2018, is one of 17 observational ones, and was the 30th registered.
2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.
Browse Low Back Pain studies →5 of the 56 studies in Low Back Pain with a site in Denmark are open now. Recruiting first, the newest first:
Rigshospitalet, Denmark · Sites in Denmark
Ages 18+
Aalborg University Hospital · Sites in Denmark
Ages 18+
Aalborg University Hospital · Sites in Denmark
Ages 18–65
Aalborg University · Sites in Denmark
Ages 18–60
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
56 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 3 3 · Phase 4 2
First in 2001; this study’s year is marked. 6 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,500 is above the median of 100 across 484 observational studies indexed under Low Back Pain.
Median enrollment 125 across the 38 interventional studies, 200 across the 17 observational. Of the 43 that completed or were terminated, 5 (12%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 56 have an industry lead sponsor. The 10 most frequent:
University of Southern Denmark is the lead sponsor of 337 studies on the registry; 47 are open to participants now.
University of Southern Denmark has 6 studies filed under Low Back Pain — fewer than ten, so there is no comparison to draw.
1 of the studies in Low Back Pain with a site in Denmark that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07378735Rigshospitalet, DenmarkBack to Life - Early Rehabilitation Therapy for Patients Undergoing Lumbar Spinal Fusion | 2026-11 |
Add it to your calendar (.ics) → With an account.
Among the 56 studies in Low Back Pain with a site in Denmark, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The GLA:D Back project evaluates the implementation of standardised patient education and exercise therapy for people with persistent or recurrent low back pain (LBP) in a hybrid implementation-effectiveness design. This involves evaluating the process of implementation as well as clinician level outcomes and patient level outcomes.
GLA:D (Good Life with OsteoArthritis in Denmark) is a non-profit initiative and registered trademark from the University of Southern Denmark. It educates clinicians in delivering evidence-based care for musculoskeletal health conditions and registers outcomes in a clinical registry. GLA:D Back uses only the acronym.
The main activity of the implementation strategy is a two-days course for physiotherapists and chiropractors in delivering patient education and exercise therapy that is aimed at supporting patient self-management of LBP. This comes with ready-to-use patient education materials and exercise programs. The course is targeted at chiropractors and physiotherapists, but any health care provider authorised to treat patients with back pain in Denmark can participate, i.e. medical doctors, physiotherapists and chiropractors.
The clinical intervention is a group-based program consisting of two sessions of patient education and 8 weeks of supervised exercises. The program uses a cognitive-behavioural approach and the aim of the exercise component is to restore the patient's ability and confidence to move freely. Clinicians decide which patients are offered the program.
The implementation process is evaluated in a dynamic process monitoring the penetration, adoption and fidelity of the clinical intervention.
The education of clinicians is evaluated via clinician-level outcomes concerning attitudes towards back pain and confidence in managing people with LBP.
The clinical intervention and potential effect mechanisms are evaluated at the patient-level in an observational design. Patients who are participating in the GLA:D Back program are followed using measures of knowledge, skills, beliefs, performance, self-efficacy and success in self-management.
Effects at a national level will be investigated via data from national registries of health care utilisation and sick-leave. Patient- and clinician reported data are collected in a registry.
The clinician training courses are open to all interested authorised back pain clinicians practicing in Denmark. The study evaluates courses conducted in 2018 which involves one or two courses for clinicians in each of five Danish regions.
The adoption of GLA:D Back is investigated by measuring the extent to which clinicians who have participated in the GLA:D Back course conduct the program in their clinics. Reach of the patient target group is determined by asking clinicians about the degree to which patients offered the treatment accept this. Fidelity with the program is investigated quantitatively by asking about treatment content and recall of key messages via patient questionnaires, and by ensuring that patients' individual goals are registered. The quality of care in terms of delivering the key elements of the intervention will be further explored qualitatively.
The profile of patients enrolled in the GLA:D Back programme will be compared between clinics and administrative regions.
Clinician level effects are investigated in an observational longitudinal design with clinician reported data collected before the clinician training course, immediately after the course and 4 months later, and with patient-reported information on delivery collected at their three-months follow up. Indicators of implementation are registration of patients in the GLA:D Back registry and that patients report receiving the educational components of care and supervised exercises. Orientation towards treatment of LBP and confidence in managing patients with LBP are evaluated by clinicians' answers to standardised questionnaires.
Patient level outcomes are aimed at investigating changes in knowledge, beliefs and skills related to the LBP condition which is hypothesized to lead to improved self-efficacy. The initial measures are related to knowledge skills, beliefs and performance, the next line of outcomes to self-efficacy, then daily activities and quality of life and last health care utilisation and work ability.
The compliance with the program is evaluated by patient report of the number of patient education sessions and exercise sessions attended.
The registry is delivered by Odense Patient data Explorative Network (OPEN) at University of Southern Denmark and uses REDCap (Vanderbilt University) as the platform for data collection. Clinicians are registered when signing up for the GLA:D Back course and agreeing to participate in research. Patients are registered by the clinician and have links to patient questionnaires sent to their email before beginning the GLA:D Back program and after 3, 6 and 12 months if consenting to their data being used for research.
Rather than testing effects on one primary outcome, the study evaluates the implementation process and a number of outcomes based on a logical model of change.
Participants are people consulting a physiotherapist or chiropractor who are trained in the GLA:D Back program. The decision to enrol a patient in GLA:D Back is at the discretion of the clinician in a dialogue with the patient, when clinicians judge that the patient would benefit from improved self-management skills
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
The decision to invite a patient to participate in the GLA:D Back program is at the discretion of the clinician. Clinicians are taught that the program was developed for people with persistent or recurrent low back pain and a need for improved self-management
Exclusion Criteria:
Back pain related to specific spinal or systemic pathology, signs of acute nerve root involvement
Two 1-hour group sessions of patient education 8 weeks of twice-weekly 1-hour supervised group exercise sessions
Behavioral: GLA:D Back
The intervention aims at improving the participant's ability to self-manage low back pain (LBP). The content is based on a cognitive behavioural approach aimed at supporting pain self-efficacy. An individual session at the beginning and the end of the group sessions involve goal-setting and physical tests. Key messages of the patient education include that pain is not a sign of danger and back pain is explained using a behavioural model of (im)balance between demands and capacity rather than emphasising tissue damage. The exercises aim at restoring natural variation in movement and provides guidance for patients in exploring movement rather than teaching exercises in only one correct manner.
Brief Illness Perceptions Questionnaire (B-IPQ)
Nine items covering the constructs of consequences, timeline (expectations of prognosis), personal control, treatment control, identity (extent of symptoms), coherence (understanding of symptoms), emotional representation, concerns, and cause. Each of the items 1 to 8 are scored 0 - 10. If internal consistency allows so a sum score is calculated (0-80). Cause is registered as text.
Time frame: Change from baseline to 3 months
Fear Avoidance Beliefs Questionnaire (FABQ)
FABQ physical activity subscale (0 = no fear avoidance beliefs; 24 = highest possible fear avoidance)
Time frame: Change from baseline to 3 months
The Arthritis Self-efficacy (ASES)
ASES subscales of pain and other symptoms. Each item is scored on a 0 - 10 scale (0 = very uncertain; 10 = very certain)
Time frame: Change from baseline to 6 months
Quality of Life (General health)
The 36-Item Short Form Health Survey (SF-36 item1); 5-point likert scale
Time frame: Proportions in response categories baseline to 12 months
Quality of Life (Social functioning)
The 36-Item Short Form Health Survey (SF-36) subdomain social functioning, transformed score 0-100
Time frame: Change from baseline to 12 months
Quality of Life (Mental functioning)
The 36-Item Short Form Health Survey (SF-36) subdomain mental functioning, transformed score 0-100
Time frame: Change from baseline to 12 months
General Health
Health thermometer from Eq-5D, score 0= worst imaginable to 100= best imaginable
Time frame: Change from baseline to 12 months
Health care visits primary care
Number of primary care visits from national registries
Time frame: During 12 months after participation
Health care visits hospital
Number of hospital visits due to LBP from national registries
Time frame: During 12 months after participation
Imaging
x-rays, MRI and CT-scans of lower back from national registries
Time frame: During 12 months after participation
Pain medication
Prescriptions of pain medication from national registries
Time frame: During 12 months after participation
Confidence with exercises
How confident are you in performing exercises in a beneficial way?' (0-10 scale from 'not confident at all' to 'absolutely confident')
Time frame: Change from baseline to 3 months
Self-assessed physical capacity
Self-assessed physical fitness visual analogue scales on perceived strength, endurance, flexibility, balance, and moving unhindered as compared with that of other people of the same age and sex. Each item is scored on a 9-point scale (1 = poor; 5 = average; 9 = super). Each item is treated as one subscale
Time frame: Change from baseline to 3 months
Satisfaction with care
Overall satisfaction with care (5-point Likert scale; 0 = Not at all satisfied, 5 = Extremely satisfied)
Time frame: 3 months
Patient reported harms or side effects
Text description of any side effects or problems experienced in relation to the participation in GLA:D Back.
Time frame: 3 months
Oswestry Disability Index
Ten items, sum score 0 - 50 recalculated to 0-100 (0 = No disability; 100 = Maximum disability)
Time frame: Change from baseline to 3, 6, 12 months
Pain Intensity
Numeric Rating Scale 0-10 for typical back pain last week (0 = no pain; 10 = worst imaginable pain)
Time frame: Change from baseline to 3, 6, 12 months
Work ability
Number of days off work after 1 month of absenteeism available from the 'DREAM' registry from the Danish Ministry of Employment
Time frame: During 12 months after participation
Brief Illness Perceptions Questionnaire (B-IPQ)
Nine items covering the constructs of consequences, timeline (expectations of prognosis), personal control, treatment control, identity (extent of symptoms), coherence (understanding of symptoms), emotional representation, concerns, and cause. Each of the items 1 to 8 are scored 0 - 10. If internal consistency allows so a sum score is calculated (0-80). Cause is registered as text.
Time frame: Change from baseline to 6, 12 months
Fear Avoidance Beliefs Questionnaire (FABQ)
FABQ physical activity subscale (0 = no fear avoidance beliefs; 24 = highest possible fear avoidance)
Time frame: Change from baseline to 6, 12 months
The Arthritis Self-efficacy (ASES)
ASES subscales of pain and other symptoms. Each item is scored on a 0 - 10 scale (0 = very uncertain; 10 = very certain)
Time frame: Change from baseline to 3, 12 months
Quality of Life (General Health)
The 36-Item Short Form Health Survey (SF-36 item 1),5-point Likert scale
Time frame: Proportions in response categories baseline to 3, 6 months
Quality of Life (Social functioning)
The 36-Item Short Form Health Survey (SF-36) subdomains social functioning, transformed score 0-100
Time frame: Change from baseline to 3, 6 months
Quality of Life /Mental functioning)
The 36-Item Short Form Health Survey (SF-36) subdomains of mental functioning, transformed score 0-100
Time frame: Change from baseline to 3, 6 months
The Pain Attitudes and Beliefs Scale for Physiotherapists (PABS-PT)
Clinician reported 19-item scale. Two subscales: biomedical orientation and behavioural orientation are scored
Time frame: Change from before course participation to 4 months
Practitioner Confidence Scale (PCS)
Clinician reported 4-item scale plus two items added to capture confidence about using a behavioral pain model
Time frame: Change from before course participation to 4 months
The Determinants of Implementation Behavior Questionnaire (DIBQ)
Clinician level measure of the implementation process. Thirty-one items from the domains of knowledge, skills, beliefs about capability, beliefs about consequences, innovation, patients, intentions, organisation, social influences, social context, behavioural regulation, and innovation strategy
Time frame: Immediately after curse participation and 4 months
Adoption
Proportion of clinicians participating in a GLA:D Back course that delivers the program
Time frame: Within 6 months
Patients participation
Clinician reported proportion of invited patients who decide to participate
Time frame: 4 months
Patient compliance
Proportion of patients enrolled in GLA:D Back that complete the program
Time frame: 3 months
Plan to share: Undecided
Started Apr 2018 (actual). Primary completion is estimated for Dec 2024, 80 months after the start.
Of 177 non-industry observational studies under Low Back Pain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 48. This study's planned 80 months is above that.
Counting every sponsor, half of 187 studies reached it within 24 months; a quarter within 10 and three quarters within 48.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Southern Denmark →